• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Approach to prolactin monitoring and hyperprolactinaemia in transgender and gender-diverse individuals undergoing gender affirming hormone therapy.

作者信息

Nolan Brendan J, Accatino Matthew I, Angus Lachlan M, Cheung Ada S

机构信息

Trans Health Research Group, Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia.

Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

出版信息

Front Endocrinol (Lausanne). 2025 May 27;16:1608108. doi: 10.3389/fendo.2025.1608108. eCollection 2025.

DOI:10.3389/fendo.2025.1608108
PMID:40496569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12148852/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9d/12148852/dd268928935a/fendo-16-1608108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9d/12148852/dd268928935a/fendo-16-1608108-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c9d/12148852/dd268928935a/fendo-16-1608108-g001.jpg

相似文献

1
Approach to prolactin monitoring and hyperprolactinaemia in transgender and gender-diverse individuals undergoing gender affirming hormone therapy.对接受性别肯定激素治疗的跨性别者和性别多样化个体进行催乳素监测及高催乳素血症的处理方法。
Front Endocrinol (Lausanne). 2025 May 27;16:1608108. doi: 10.3389/fendo.2025.1608108. eCollection 2025.
2
Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.自我开具性别确认激素疗法的跨性别女性体内激素浓度：一项回顾性研究。
J Sex Med. 2022 May;19(5):864-871. doi: 10.1016/j.jsxm.2022.02.023. Epub 2022 Apr 1.
3
Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment.高泌乳素血症与接受性别肯定激素治疗的跨性别女性中的泌乳素瘤相关。
Endocrine. 2021 May;72(2):524-528. doi: 10.1007/s12020-020-02563-3. Epub 2021 Jan 4.
4
Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.性别肯定激素治疗对跨性别者的影响——一项回顾性队列研究
Endocrine. 2024 Jul;85(1):370-379. doi: 10.1007/s12020-024-03736-0. Epub 2024 Feb 22.
5
Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy.出生时被指定为女性的跨性别者的骨骼健康：性别肯定激素治疗和性腺切除术的影响。
Front Endocrinol (Lausanne). 2024 Sep 26;15:1416121. doi: 10.3389/fendo.2024.1416121. eCollection 2024.
6
The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.泰国 transgender 人群中性别确认激素使用的真实世界特征。 （注：“transgender”常见释义为“跨性别者” ）
Sex Med. 2022 Jun;10(3):100513. doi: 10.1016/j.esxm.2022.100513. Epub 2022 Apr 12.
7
Development and Growth of Intracranial Meningiomas in Transgender Women Taking Cyproterone Acetate as Gender-Affirming Progestogen Therapy: A Systematic Review.接受醋酸环丙孕酮作为性别确认孕激素治疗的跨性别女性颅内脑膜瘤的发生与生长：一项系统评价
Transgend Health. 2022 Nov 29;7(6):473-483. doi: 10.1089/trgh.2021.0025. eCollection 2022 Nov.
8
Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents. transgender 青少年进行性别肯定激素治疗期间的实验室变化。
Pediatrics. 2024 May 1;153(5). doi: 10.1542/peds.2023-064380.
9
Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.澳大利亚跨性别和性别多样化成年人的性别肯定激素治疗。
Intern Med J. 2024 Sep;54(9):1450-1457. doi: 10.1111/imj.16413. Epub 2024 Jul 26.
10
The thrombin generation potential increases after feminizing gender-affirming hormone treatment, decreases after masculinizing gender-affirming hormone treatment, and is determined by the hormone treatment regimen.在进行女性化性别确认激素治疗后，凝血酶生成潜力增加；在进行男性化性别确认激素治疗后，凝血酶生成潜力降低，且其由激素治疗方案决定。
J Thromb Haemost. 2025 Mar 14. doi: 10.1016/j.jtha.2025.03.006.

本文引用的文献

1
Laboratory Monitoring in Transgender and Gender-Diverse Individuals.跨性别和性别多样化个体的实验室监测
Clin Chem. 2025 Mar 3;71(3):358-377. doi: 10.1093/clinchem/hvaf001.
2
The use of psychiatric medications and associated factors among people receiving care at a transgender outpatient clinic in Southern Brazil, 2021-2022.2021 - 2022年巴西南部一家跨性别门诊诊所接受治疗的人群中精神科药物的使用及相关因素
Epidemiol Serv Saude. 2024 Dec 6;33(spe1):e2024170. doi: 10.1590/S2237-96222024v33e2024170.especial.en. eCollection 2024.
3
Effect of Spironolactone and Cyproterone Acetate on Breast Growth in Transgender People: A Randomized Clinical Trial.
螺内酯和醋酸环丙孕酮对跨性别者乳房发育的影响：一项随机临床试验。
J Clin Endocrinol Metab. 2025 May 19;110(6):e1874-e1884. doi: 10.1210/clinem/dgae650.
4
Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.澳大利亚跨性别和性别多样化成年人的性别肯定激素治疗。
Intern Med J. 2024 Sep;54(9):1450-1457. doi: 10.1111/imj.16413. Epub 2024 Jul 26.
5
The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women.不同抗雄激素药物在中国跨性别女性中的疗效及用户满意度
Int J Transgend Health. 2024 Mar 14;25(3):471-482. doi: 10.1080/26895269.2024.2323514. eCollection 2024.
6
Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy.在接受激素治疗的 2 年内，跨性别和性别多样化成年人的精神药物处方模式和潜在的药物-激素相互作用。
J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):283-289.e2. doi: 10.1016/j.japh.2023.10.005. Epub 2023 Oct 13.
7
Changes in laboratory results in transgender individuals on hormone therapy - a retrospective study and practical approach.接受激素治疗的 transgender 个体实验室检查结果的变化——一项回顾性研究及实用方法
Eur J Endocrinol. 2023 May 24. doi: 10.1093/ejendo/lvad052.
8
A systematic review of psychosocial functioning changes after gender-affirming hormone therapy among transgender people.跨性别者接受性别肯定激素治疗后心理社会功能变化的系统评价。
Nat Hum Behav. 2023 Aug;7(8):1320-1331. doi: 10.1038/s41562-023-01605-w. Epub 2023 May 22.
9
The Effect of Gender-Affirming Hormones on Gender Dysphoria, Quality of Life, and Psychological Functioning in Transgender Individuals: A Systematic Review.性别肯定激素对跨性别者性别焦虑、生活质量和心理功能的影响：一项系统综述。
Transgend Health. 2023 Feb 8;8(1):6-21. doi: 10.1089/trgh.2020.0094. eCollection 2023 Feb.
10
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.《跨性别和性别多样化人群健康照护标准》第8版
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. doi: 10.1080/26895269.2022.2100644. eCollection 2022.